Leading the Way in Life Science Technologies

GEN Exclusives

More »

Sidebars

More »
Mar 15, 2009 (Vol. 29, No. 6)

GEN BIO Theater Presentations

  • GEN will sponsor a series of Theater presentations at the BIO Int’l Conference in Atlanta on May 19 and 20. The talks, which will take place at Booth 5807, will provide a venue for visitors in the exhibit hall to learn, at no cost, about the latest advances in drug discovery, therapeutic development, and global clinical trial activities and to delve into the operational aspects of running a biotechnology or biomanufacturing company in the 21st Century.

    Presentations will continue throughout the day on Tuesday and Wednesday. Plan to spend several hours at our theater, and bring a colleague! We look forward to seeing you there.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »